U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing

Michael E. Klepser, Alex J. Adams, Paul Srnis, Matthew Mazzucco, Donald Klepser

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Community pharmacies are among the most accessible health professionals, and they are increasingly offering CLIA-waived tests. This manuscript aims to determine: 1) the current number of pharmacies in the United States with CLIA-waivers; 2) the uptake of CLIA-waivers by different pharmacy store types; and 3) the state-by-state differences in the percentage of pharmacies with a CLIA-waiver. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention CLIA Laboratory Search website on May 3rd, 2015. The website allows for exportation of demographic data on all CLIA-waived facilities by state. Results: Pharmacies are currently the fourth highest-ranking facility of CLIA-waived laboratories with 10,838 locations. Supermarkets had the highest percentage of pharmacies with a CLIA-waiver (43.16%). States demonstrated considerable variability in the percentage of pharmacies with a CLIA-waiver, with a median percentage of 19.56% (0%-60.00% range). Conclusions: Community pharmacies are currently a leading facility for CLIA-waived laboratories. Substantial state-level variation is observed in the percentage of pharmacies with CLIA-waivers, and these differences may be driven by restrictions in state law or regulations.

Original languageEnglish (US)
Pages (from-to)614-621
Number of pages8
JournalResearch in Social and Administrative Pharmacy
Volume12
Issue number4
DOIs
StatePublished - Jul 1 2016

Fingerprint

Clinical laboratories
Pharmacies
Testing
Websites
Disease control

Keywords

  • CLIA-waived laboratories
  • Community pharmacy
  • Point-of-care testing

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science

Cite this

U.S. community pharmacies as CLIA-waived facilities : Prevalence, dispersion, and impact on patient access to testing. / Klepser, Michael E.; Adams, Alex J.; Srnis, Paul; Mazzucco, Matthew; Klepser, Donald.

In: Research in Social and Administrative Pharmacy, Vol. 12, No. 4, 01.07.2016, p. 614-621.

Research output: Contribution to journalArticle

@article{6ae9c8e7bdb04608ba87893270348072,
title = "U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing",
abstract = "Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Community pharmacies are among the most accessible health professionals, and they are increasingly offering CLIA-waived tests. This manuscript aims to determine: 1) the current number of pharmacies in the United States with CLIA-waivers; 2) the uptake of CLIA-waivers by different pharmacy store types; and 3) the state-by-state differences in the percentage of pharmacies with a CLIA-waiver. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention CLIA Laboratory Search website on May 3rd, 2015. The website allows for exportation of demographic data on all CLIA-waived facilities by state. Results: Pharmacies are currently the fourth highest-ranking facility of CLIA-waived laboratories with 10,838 locations. Supermarkets had the highest percentage of pharmacies with a CLIA-waiver (43.16{\%}). States demonstrated considerable variability in the percentage of pharmacies with a CLIA-waiver, with a median percentage of 19.56{\%} (0{\%}-60.00{\%} range). Conclusions: Community pharmacies are currently a leading facility for CLIA-waived laboratories. Substantial state-level variation is observed in the percentage of pharmacies with CLIA-waivers, and these differences may be driven by restrictions in state law or regulations.",
keywords = "CLIA-waived laboratories, Community pharmacy, Point-of-care testing",
author = "Klepser, {Michael E.} and Adams, {Alex J.} and Paul Srnis and Matthew Mazzucco and Donald Klepser",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.sapharm.2015.09.006",
language = "English (US)",
volume = "12",
pages = "614--621",
journal = "Research in Social and Administrative Pharmacy",
issn = "1551-7411",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - U.S. community pharmacies as CLIA-waived facilities

T2 - Prevalence, dispersion, and impact on patient access to testing

AU - Klepser, Michael E.

AU - Adams, Alex J.

AU - Srnis, Paul

AU - Mazzucco, Matthew

AU - Klepser, Donald

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Community pharmacies are among the most accessible health professionals, and they are increasingly offering CLIA-waived tests. This manuscript aims to determine: 1) the current number of pharmacies in the United States with CLIA-waivers; 2) the uptake of CLIA-waivers by different pharmacy store types; and 3) the state-by-state differences in the percentage of pharmacies with a CLIA-waiver. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention CLIA Laboratory Search website on May 3rd, 2015. The website allows for exportation of demographic data on all CLIA-waived facilities by state. Results: Pharmacies are currently the fourth highest-ranking facility of CLIA-waived laboratories with 10,838 locations. Supermarkets had the highest percentage of pharmacies with a CLIA-waiver (43.16%). States demonstrated considerable variability in the percentage of pharmacies with a CLIA-waiver, with a median percentage of 19.56% (0%-60.00% range). Conclusions: Community pharmacies are currently a leading facility for CLIA-waived laboratories. Substantial state-level variation is observed in the percentage of pharmacies with CLIA-waivers, and these differences may be driven by restrictions in state law or regulations.

AB - Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Community pharmacies are among the most accessible health professionals, and they are increasingly offering CLIA-waived tests. This manuscript aims to determine: 1) the current number of pharmacies in the United States with CLIA-waivers; 2) the uptake of CLIA-waivers by different pharmacy store types; and 3) the state-by-state differences in the percentage of pharmacies with a CLIA-waiver. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention CLIA Laboratory Search website on May 3rd, 2015. The website allows for exportation of demographic data on all CLIA-waived facilities by state. Results: Pharmacies are currently the fourth highest-ranking facility of CLIA-waived laboratories with 10,838 locations. Supermarkets had the highest percentage of pharmacies with a CLIA-waiver (43.16%). States demonstrated considerable variability in the percentage of pharmacies with a CLIA-waiver, with a median percentage of 19.56% (0%-60.00% range). Conclusions: Community pharmacies are currently a leading facility for CLIA-waived laboratories. Substantial state-level variation is observed in the percentage of pharmacies with CLIA-waivers, and these differences may be driven by restrictions in state law or regulations.

KW - CLIA-waived laboratories

KW - Community pharmacy

KW - Point-of-care testing

UR - http://www.scopus.com/inward/record.url?scp=84951127131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951127131&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2015.09.006

DO - 10.1016/j.sapharm.2015.09.006

M3 - Article

C2 - 26508268

AN - SCOPUS:84951127131

VL - 12

SP - 614

EP - 621

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1551-7411

IS - 4

ER -